Banning one measure of the effectiveness of healthcare interventions could come at a high cost

Blog: USAPP

Abstract

Health policymakers have choices about which health interventions they are able to fund, interventions that often differ in cost and effectiveness. Parker Tomkinson and Emily Adrion look at a commonly used form of health technology assessment, the quality-adjusted life year, or QALY, a measure the US Congress may ban. They write that despite the widespread … Continued